Supplementary Figure S13 from PKCβ Inhibitor MS-553 Displays Preclinical Efficacy in Both Treatment-Naïve and BTK Inhibitor–Resistant Chronic Lymphocytic Leukemia
Year: 2026
Type: supplementary-materials
Abstract: MS-553 inhibits the transcription of downstream BCR and Wnt/β-catenin signaling components.
Authors: Britten K. Gordon, Elizabeth M. Muhowski, Jyotsana Singh, Janani Ravikrishnan, Arnau Peris-Cuesta, Daisy Diaz Rohena, John R. Sanchez, Shanmugapriya Thangavadivel, Samon Benrashid, Alexander He, Alexander R. Marr, Andrew D. Mitchell, Jazmin M. Urrutia, Shrilekha Misra, Tzung-Huei Lai, Lianbo Yu, Brandi R. Walker, Elizabeth Perry, Sachet A. Shukla, Nicole R. Grieselhuber, Kerry A. Rogers, Rosa Lapalombella, James S. Blachly, Adam S. Kittai, Seema A. Bhat, Nitin Jain, William G. Wierda, John C. Byrd, Michael Niesman, Kai Zhang, Deepa Sampath, Jennifer A. Woyach
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W7122526428